Back to Search
Start Over
Supplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....9e568b16421048c1e79b8dfceca7e687
- Full Text :
- https://doi.org/10.1158/2159-8290.22541198.v1